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I. Introduction 
Almost every practicing physician is aware that the utilization of diagnostic radiological 
techniques and radiation therapy utilizing ionizing radiation has increased substantially over the 
past 30 years.1 In 1980 the USA population received 20% of their exposure to ionizing radiation 
from medical care. The National Council on Radiation Protection (NCRP) No. 160 (2009) 
reported that almost 50% of the population’s radiation exposure came from medical care. 
Unfortunately, this increased exposure has been presented in the newspapers, television and 
internet and in many instances the risks of birth defects, miscarriage and cancer have been 
exaggerated and the benefits ignored. It is important for physicians to become as knowledgeable 
about the risks of ionizing radiation as they are about its benefits. Although pulmonologists do 
not concentrate their practice on pregnant women or women of reproductive age, these patients 
will be part of their practice. An important concern is that many women will visit their physician 
and not know they are pregnant, or worse, will become pregnant between the time of the office 
visit and the appointment for the radiological exam. These situations can be concerning for the 
patient and the physician. In order for the physician to interpret the various forms of exposure 
measurement Table 1 lists the various nomenclatures for radiation exposures so that the reader 
will be able to understand radiation exposures in the terms with which they may be familiar. 
Pulmonologists are fortunate with regard to the specific studies they request in order to 
provide clinical care, since most of the diagnostic tests do not directly expose the uterus (embryo) 
or ovary. Radiography of the chest, head, neck, dental or extremity exposes the embryo or ovary 
to miniscule (insignificant) exposures of radiation. In some instances there is no exposure at all. 
The pulmonologist may infrequently order diagnostic studies for a patient that exposes 
the abdomen or pelvis but should be aware of other studies that could have been ordered by other 
providers. Fortunately, the vast majority of diagnostic studies exposing the abdomen or pelvis 
expose the embryo or ovary to less than 10 rad (0.1 Gy) 
 
II. The reproductive and developmental risks of exposures of ionizing radiation to 
pregnant or potentially pregnant women. 
The reproductive and developmental risks of in utero exposures to ionizing radiation are 
listed below (Tables 2 and 3) 
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1) Birth defects, mental retardation, other neurobehavioral effects, growth retardation and 
embryonic death (miscarriage) are deterministic effects (Threshold effects). This indicates that 
these effects have a NOAEL (no adverse effect level). Almost all diagnostic radiological 
procedures provide exposures that are below the NOAEL for these developmental effects. 
Diagnostic radiological studies rarely exceed 10 rad (0.1 Gy), while the threshold for congenital 
malformations or miscarriage is > 20 rad (0.2 Gy). (Table 2).  
2) In order for the embryo to be deleteriously affected by ionizing radiation when the 
mother is exposed to a diagnostic study, the embryo has to be exposed above the NOAEL to 
increase the risk of deterministic effects. This rarely happens when pregnant women have x-ray 
studies of the head, neck, chest or extremities.  
3) During the pre-implantation and pre-organogenesis stages of embryonic development 
the embryo is least likely to be malformed by the effects of ionizing radiation because the cells of 
the very young embryo are omnipotent and can replace adjacent cells that have been deleteriously 
affected. This early period of development has been designated as “the all or none period.” 
4) Protraction and fractionation of exposures of ionizing radiation to the embryo decrease 
the magnitude of the deleterious effects of deterministic effects. The more protracted or 
fractionated the radiation the lower the risk because the threshold increases. 
5) The increased risk of cancer following high level of exposures to ionizing radiation 
exposure in adult populations has been demonstrated in the survivors of atomic bomb. Radiation-
induced carcinogenesis is assumed to be a stochastic effect (nonthreshold effect) so that there is 
theoretically a risk at low exposures. While there is no question that high-level exposures of 
ionizing radiation can increase the risk of cancer, the magnitude of the risk of cancer from 
embryonic exposures following diagnostic radiological procedures is controversial. Recent 
publications and analyses indicate that the risk is lower for the irradiated embryo than the 
irradiated child, which surprised many scientists interested in this subject (Tables 4- 6)2. 
 
III. Evaluating the risks of radiation exposure to the developing embryo 
 When evaluating the risks of ionizing radiation, the physician is faced with several 
different clinical situations: 
 Situation 1 
 4 
The pulmonologists are very fortunate because the radiological tests that would be 
ordered for their patients will not expose the embryo directly and therefore the embryo will not 
receive an exposure that would increase the embryo’s risk for birth defects, miscarriage, growth 
retardation, mental retardation or neural behavioral effects (Table 7). Table 7 lists many 
frequently used diagnostic radiological and radionuclide tests. Note that none of the tests exceed 
exposures of 10 rad (0.1 Gy or 100 mGy) except for radiation therapy or extensive fluoroscopy to 
the abdomen or pelvis. 
Although most diagnostic radiological studies of the abdomen or pelvis do not expose the 
embryo to more than 10 rad (0.10 Gy), the family is upset because they are aware that the embryo 
was directly exposed. Under these circumstances it may be necessary to request the Health 
Physicist to calculate the actual exposure in order to be able to allay the family’s concern with the 
actual exposure.  
Situation 2 
The pregnant patient presents with clinical symptoms that need to be evaluated.  What is 
the appropriate utilization of diagnostic radiological procedures that may expose the embryo or 
fetus to ionizing radiation? 
 A pregnant or possibly pregnant woman complaining of chest symptoms that cannot be 
attributed to pregnancy deserves the appropriate studies to diagnose and treat her clinical 
problems, including radiological studies.  Furthermore, these studies should not be relegated to 
one portion of the menstrual cycle if she has not yet missed her period. The studies should be 
performed at the time they are clinically indicated whether or not the woman is in the first or 
second half of the menstrual cycle. During the 2nd half of the menstrual cycle the pregnancy test 
may be negative even though the patient is pregnant. This should be explained to the patient and 
family. 
 Situation 3 
 A patient has completed a diagnostic procedure that has exposed her uterus to ionizing 
radiation.  Her pregnancy test result was negative. She believes she was pregnant at the time of 
the procedure. What is your response to this situation? 
 Explain that you would have proceeded with the necessary radiological diagnostic test 
whether the patient was pregnant or not because diagnostic studies that are indicated in the 
patient have to take priority over the possible risk to her embryo; however, almost 100% of 
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diagnostic studies do not increase the risks to the embryo (Table 1). Second, she must have been 
very early in her pregnancy because her pregnancy test result was negative. At this time, obtain 
the calculated dose to the embryo and determine her stage of pregnancy.  If the dose is below 10 
rad (0.1 Gy; 0.1 Sv), you can inform the patient that her risks for birth defects and miscarriage 
have not been increased. In fact, the threshold for these effects is 20 rad (0.2Gy) at the most 
sensitive stage of embryonic development (Table 2). Of course, you are obligated to tell her that 
every healthy woman is at risk for the background incidence of birth defects and miscarriage, 
which is 3% for birth defects and 15% for miscarriage (Table 3). 
 Situation 4 
 A woman delivers a baby with serious birth defects.  On her first postpartum visit, she 
recalls that she had a diagnostic X-ray study early in her pregnancy.  What is your response when 
she asks you whether the baby's malformation could be caused by the radiation exposure? 
 In most instances, the nature of the clinical malformations will rule out radiation 
teratogenesis (microcephaly, mental retardation and fetal growth retardation).  In such a case, a 
clinical teratologist or radiation embryologist could be of assistance.  On the other hand, if the 
exposure is below 10 rad (0.1 Gy), it would not be scientifically supportable to indicate that the 
radiation exposure was the cause of the malformation. The threshold for malformations is 20 rad 
(0.20 Gy) (Table 2). The dose, timing, and nature of the malformation are considered in this 
analysis. 
 To appropriately and more completely respond to these questions, the physician should 
rely on the extensive amount of available information on the effects of radiation on the embryos.  
In fact, there is no environmental hazard that has been more extensively studied or on which 
more information is available (Tables 2 and 4).3-12  
 
IV. Radiation risks to the embryo 
 An acute exposure to ionizing radiation more than 50 rad represents a significant risk to 
the embryo, regardless of the stage of gestation. 6-9, 12, 13 The threshold dose for low energy 
transfer ionizing radiation that results in an increase in malformations is approximately 20 rad 
(0.2 Gy) (Table 2).  Although congenital malformations are unlikely to be produced by radiation 
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during the first 14 days of human development, there would be a substantial risk of embryonic 
loss if the dose is high.  From approximately the 18th day to the 40th day postconception, the 
embryo would be at risk for an increased frequency of anatomic malformations if the radiation 
exposure exceeds 20-25 rad (0.2-0.25 Gy).  Until about the 15th week, the embryo has an 
increased susceptibility to central nervous system (CNS) effects, major CNS malformations early 
in gestation and mental retardation in midgestation. Of course, with very high doses, in the 
hundreds of rads, mental retardation can occur in the later part of gestation.  Although it is true 
that the embryo is vulnerable to the deleterious effects of these midrange exposures of ionizing 
radiation, the measurable effects fall off rapidly as the exposure approaches the usual levels that 
the embryo receives from diagnostic radiologic procedures (<10 rad; 0.1 Gy).  The threshold of 
20 rad (0.2 Gy) at the most vulnerable stage of development (20-25 days post conception) is 
increased by protraction of the radiation exposure. If a pregnant woman had a series of 
radiographic analyses over a period of three to four days that totaled 15 rad (0.15 Gy), there 
would be no increased risk for any of the developmental threshold (deterministic) effects.6,12,13 
The recommendations of most radiation embryologists indicate that exposures in the diagnostic 
range will not increase the risk of birth defects or miscarriage.6.8.9.12 Table 4 compares the 
spontaneous risks facing an embryo at conception and the risks from a low exposure of ionizing 
radiation (10 rad; 100 mGy 10,000 mrad).   
 Therefore, the hazards of exposures in the range of diagnostic roentgenology (20-10,000 
mrad [0.2mGy-0.1 Gy]) present an extremely low risk to the embryo when compared with the 
spontaneous mishaps that can befall human embryos (Table 3 and 4). Approximately 30-40 % of 
human embryos abort spontaneously (many abort before the first missed menstrual period) Table 
3. Human infants have a 3 % major malformation rate at term that increases to approximately 6% 
to 8 % once all minor malformations are recorded.  Although doses of 1-3 rad (0.01-0.03 Gy) can 
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produce cellular effects and the fact that diagnostic radiation exposure during pregnancy has been 
associated with malignancy in childhood, the maximum theoretical risk to human embryos 
exposed to doses of 10 rads or less is extremely small.  When the data and risks are explained to 
the patient, the family with a wanted pregnancy invariably continues with the pregnancy. 
 A frequent difficulty is that the risks from diagnostic radiation are evaluated outside the 
context of the significant normal risks of pregnancy.  Furthermore, many physicians approach the 
evaluation of diagnostic radiation exposure with either of two extremes:  a cavalier attitude or 
panic.  The usual procedures in clinical medicine are ignored, and an opinion based on meager 
information is given to the patient.  Frequently, this attitude reflects the physician's bias about 
radiation effects or his or her ignorance of radiation biology.  We have patient records in our files 
of scores of patients who were not properly evaluated but were advised to have an abortion 
following radiation exposure.  The following case history is an example. 
V. Case report 
A 33 year old woman was diagnosed with breast cancer and radiation therapy of the 
breast was initiated. Four weeks into her therapy it was discovered that she was 11 weeks 
pregnant. The oncologist, radiation therapist and surgeon all encouraged the future mother and 
family to abort the pregnancy. She already had received 3800 rads (3.8 Gy) to the breast. The 
family asked for another opinion and our counseling service was contacted. The health physicist 
at the consultee institution had calculated that the fetus had received 50 rads over a period of 
almost 4 weeks.  On each day of therapy the fetus had received 0.9 rad. Each week the fetus had 
2 days without being exposed. The future mother’s physicians still suggested a therapeutic 
abortion, but with less certainty. They asked me what I would tell her. I said that “I would not tell 
her anything. I wanted to talk with her.” 
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When we were able to talk, she immediately asked what should I do? I responded, “Do 
you have any questions?  She asked, “Could my baby be malformed”? I told her that 3 % of 
babies are malformed. That is the background incidence, but in her case the fetus’s risks for 
major birth defects were not increased for two reasons. The radiation was initiated in the seventh 
week after all the organs had formed and more important the dose each day was too low to 
produce malformations at any stage of pregnancy. Then she asked whether her baby could be 
severely mentally retarded. I answered her in the negative. But I also had to tell her that one in 
200 children is born mentally retarded. She then asked whether the baby could be growth 
retarded. I responded that 4% of newborns are growth retarded, but that the radiation exposure 
would not cause significant growth retardation. Finally, she asked, could my baby be normal? I 
said, “Yes.” 
The mother decided to keep the pregnancy and she delivered a 6 pound 11 ounce baby 
boy who was physically normal and has been developing, according to the mother, “very 
normally.” 
 
VI. Evaluating the patient 
 Case histories are transmitted to our laboratory frequently.  In 2008, we had 2,200,000 
hits on our pregnancy website of the Health Physics Society, “Ask the Expert”. There were 
760,000 downloads and 1646 direct consultations. In most instances the dose to the embryo is < 
10 rads (0.1 Gy) and frequently is < 1 rad (.01 Gy).  Our experience has taught us that there are 
many variables involved in radiation exposure to a pregnant or potentially pregnant woman. 
Therefore, there is no routine or predetermined advice that can be given in this situation.  
However, if the physician takes a systematic approach for the evaluation of the possible effects of 
radiation exposure, he/she can help the patient make an informed decision about continuing the 
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pregnancy.  This systematic evaluation can begin only when the following information has been 
obtained: 
• Stage of pregnancy at the time of exposure 
• Menstrual history 
• Previous pregnancy history 
• Family history of congenital malformations, miscarriages 
• Other potentially harmful environmental factors during the pregnancy 
• Ages of the mother and father 
• Type of radiation study, dates and number of studies performed 
• Calculation of the embryonic exposure by a medical physicist or competent 
 radiologist 
• Status of the pregnancy:  wanted or unwanted 
 
 The evaluation should be concluded, with both patient and counselor arriving at a 
decision. The physician should place a summary of the following information in the medical 
record. It should state that the patient has been informed that every pregnancy has a significant 
risk of problems and that the decision to continue the pregnancy does not mean that the counselor 
is guaranteeing the outcome of the pregnancy.  The use of amniocentesis and ultrasound to 
evaluate the fetus is an individual decision that would have to be made in each pregnancy. 
Each consultation should include the following statement. “If you are healthy, young 
(under 35) and have no personal or family history of reproductive or fetal developmental 
problems, then you began this pregnancy with a risk of 3% for birth defects and 15% for 
miscarriage. These are background risks faced by all pregnant women. Good luck with this 
pregnancy and keep in touch.”  
 
VII. The Carcinogenic effects of radiation 
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 The carcinogenic risks of in-utero radiation is an important topic that cannot be addressed 
adequately in this article. In 1956, Stewart et al. (13) published the results of her case control 
studies indicating the diagnostic radiation from pelvimetry was associated with a 50% increased 
risk of childhood leukemia (Table 4). That would change the risk of childhood leukemia from 40 
cases per million to 60 cases per million in the population of exposed fetuses. This has been a 
very controversial subject. 12-17 SA recent publication by Preston et al. (2) presented data from the 
in utero population of the A-bomb survivors which indicated that the embryo was less vulnerable 
to the oncogenic effects of ionizing radiation than the child. It appears that the embryo is much 
less vulnerable to the oncogenic effects of radiation than previous investigators have believed. 
Patients can be told that the fetal risk is extremely small, so small that we cannot measure the 
risks because such a large exposed population would be necessary (Tables 3, 4 and 5). Even if 
one accepts the controversial concept that the embryo is more vulnerable to the carcinogenic 
effects of radiation than the child, the risk at these low exposures is much, much  smaller that the 
spontaneous risks (1). Furthermore, other studies indicate that Stewart's (13) estimate of the risk 
involved is exaggerated. 10-11, 15-17 
 
VIII. Diagnostic or therapeutic abdominal radiation in women of reproductive age 
 In women of reproductive age, it is important for the patient and physician to be aware of 
the pregnancy status of the patient before performing any type of X-ray procedure in which the 
ovaries or uterus will be exposed. If the embryonic exposure will be 10 rad (0.1 Gy) or less, the 
radiation risks to the embryo are very small when compared with the spontaneous risks (Tables 
2-5). Even if the exposure is 10 rad (0.1 Gy), this exposure is far from the threshold or no-effect 
dose of 20 rad. The patient will accept this information if it is offered as part of the preparation 
for the radiological studies at a time when both the physician and patient are aware that a 
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pregnancy exists or may exist. The pregnancy status of the patient should be determined and 
noted. 
 Because the risks of 10-rad (0.1 Gy) fetal irradiation are so small, the immediate medical 
care of the mother should take priority over the risks of diagnostic radiation exposure to the 
embryo.  Radiological studies that are essential for optimal medical care of the mother and 
evaluation of medical problems that need to be diagnosed or treated should not be postponed.  
Elective procedures such as employment examinations or follow-up examinations, once a 
diagnosis has been made, need not be performed on a pregnant woman even though the risk to 
the embryo is very small. If other procedures (e.g., magnetic resonance imaging or ultrasound) 
can provide adequate information without exposing the embryo to ionizing radiation, then of 
course they should be used. Naturally, there is a period when the patient is pregnant but the 
pregnancy test is negative and the menstrual history is of little use. However, the risks of 
exposure to 10 rad (0.1 Gy) or less are extremely small during this period of gestation (all or 
none period,4 first two weeks).  The patient will benefit from knowing that the diagnostic study 
was indicated and should be performed in spite of the fact that she may be pregnant. 
 
IX. Scheduling the examination 
 When elective radiological studies need to be scheduled, it is difficult to know whether to 
schedule them during the first half of the menstrual cycle just before ovulation or during the 
second half of the menstrual cycle, when most women will not be pregnant. The genetic risk of 
diagnostic exposures to the oocyte or the embryopathic effects on the preimplanted embryo are 
extremely small, and there are no data available to compare the relative risk of 10 rad (0.1 Gy) to 
the oocyte or the preimplanted embryo. If the diagnostic study is performed in the first 14 days of 
the menstrual cycle, the patient should be advised to defer conception for several months, based 
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on the assumption that the deleterious effect of radiation to the ovaries decreases with increasing 
time between radiation exposure and a subsequent ovulation?  The physician is in a quandary 
because he may be warning the patient about a very-low-risk phenomenon.  On the other hand, 
avoiding conception for several months is not an insurmountable hardship.  This potential genetic 
hazard is quite speculative for man, as indicated by the report by the NCRP and BEIR committee 
report dealing with preconception radiation1, 6 
“It is not known whether the interval between irradiation of the gonads and 
conception has a marked effect on the frequency of genetic changes in human 
offspring, as has been demonstrated in the female mouse. Nevertheless, it may be 
advised for patients receiving high doses to the gonads (>25 rads) to wait for 
several months after such exposures before conceiving additional offspring.” 3. 
 Because the patients exposed during diagnostic radiologic procedures absorb 
considerably less than 25 rads, the recommendations made here may be unnecessary, but it 
involves no hardship to the patient.  Because both the NCRP and ICRP have previously 
recommended that elective radiologic examinations of the abdomen and pelvis be performed 
during the first part of the menstrual cycle (10-day rule, 14-day cycle) to protect the zygote from 
possible but largely conjectural hazards, the recommendation to avoid fertilization of recently 
irradiated ova perhaps merits equal attention. 
 
X. Importance of determining pregnancy status of patient 
 If exposures less than 10 rads (0.1 Gy) do not measurably affect the exposed embryos, 
and it is recommended that diagnostic procedures should be performed at any time during the 
menstrual cycle, if necessary, for the medical care of the patient, then the question of expending 
energy to determine the pregnancy status of the patient arises. 
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 There are several reasons why the physician and patient should share the burden of 
determining the pregnancy status before performing a radiological or nuclear medicine procedure 
that exposes the uterus: 
 1. If the physician is forced to include the possibility of pregnancy in the differential 
diagnosis, a small percentage of diagnostic studies may no longer be considered necessary.  Early 
symptoms of pregnancy may mimic certain types of gastrointestinal or genitourinary disease. 
 2. If the physician and patient are both aware that pregnancy is a possibility and the 
procedure is still performed, it is much less likely that the patient will be upset if she 
subsequently proves to be pregnant. 
 3. The careful evaluation of the reproductive status of women undergoing diagnostic 
procedures will prevent many unnecessary lawsuits.  Many lawsuits are stimulated by the factor 
of surprise.  In some instances, the jury is not concerned with cause and effect but with the fact 
that something was not done properly by the physicians. 18, 19 In this day and age, failure to 
communicate adequately can be interpreted as less-than-adequate medical care. Both these 
factors are eliminated if the patient's pregnancy status has been evaluated properly and the 
situation discussed adequately with the patient. Physicians are going to have to learn that 
practicing good technical medicine may not be good enough in a litigation-prone society. Even 
more important, the patient will have more confidence if the decision to continue the pregnancy 
is made before the medical radiological procedure is performed, because the necessity of 
performing the procedure would have been determined with the knowledge that the patient was 
pregnant. In every consultation dealing with the exposure of the embryo to diagnostic studies 
involving ionizing radiation (radiography, computed tomography, use of radionuclides) in which 
the reproductive risks or developmental risks for a fetus have not been increased by the radiation 
exposure, the patient should be informed that every healthy woman with a negative personal and 
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genetic family reproductive history has background reproductive risks which are 3% for birth 
defects and 15% for miscarriage. these background risks cannot be changed.
 15 
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Table 1 
Ionizing radiation Exposure Terminology* 
rad (rem) millirad; millirem Gray (Gy) Sievert (Sv) 
0.001 1 0.01 mGy 0.01 mSv 
0.01 10 0.1 mGy 0.1 mSv 
0.1 100 1 mGy 1 mSv 
1 1000 0.01 mGy   0.01 Sv 
10 10,000 0.1 mGy   0.1 Sv 
100 100,000  1 Gy 1 Sv 
* The rad and the rem, and the Gray and Sievert are identical for exposures of low energy 
transfer (LET) radiation, i.e, x-rays, gamma rays, beta rays, and protons. These forms of 
radiation have a Relative Biological Effectiveness (RBR) rated at one. Exposures to alpha 
rays and neutrons have a biological effectiveness greater than one. The rem and the 
Sievcert take into consideration the RBE of the radiation. For clinicians, the RBE is 
infrequently relevant, because most radiological procedures utilize radiation with an RBE 
of 1 so the Gray and Sievert exposures will be identical. 
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Table 2.  Radiation effects at different stages of gestation* 
Stage, Gestation Weeks Effect 
First and second weeks post last 
menstrual period.(LMP) (Prior to 
conception) 
First two weeks post first day of the last menstrual period. This is 
preconception radiation. Mother has not yet ovulated 
Third and fourth week of gestation 
(First two weeks post conception) 
Minimum human acute lethal dose (from animal studies). 
Approximately 0.15-0.20 Gy. Most sensitive period for the induction 
of embryonic death. No increase risk of malformations in surviving 
fetuses. “All or none stage” 
Fourth to eighth week of gestation 
(Second to sixth week post 
conception) 
Minimum lethal dose (from animal studies). At 18 day post 
conception = 0.25 Gy (25 rad). After 50 days post conception >0.50 
Gy (50 rad).  
Embryo is vulnerable to the induction of major malformations. 
Threshold for malformations > 0.2 Gy to 0.5 Gy, depending on the 
malformation. 
Minimum dose for growth retardation. At 18-36 days = 0.20-0.50 Gy 
(20 rad-50 rad). At 36-110 days = 0.25-0.50 Gy.(25 to 50 rad) But 
the induced growth retardation during this period is not as severe as 
during mid-gestation (8-15 wks) from similar exposures and is more 
recuperable (Rugh, 1962). 
Eighth to fifteenth week of 
gestation 
Most sensitive period for irreversible whole body growth retardation, 
microcephaly and severe mental retardation. Threshold for severe 
metal retardation is0.35 to 0.50 Gy (35-50 rad). Miller believes the 
threshold is > 0.5 Gy. Decrease in I.Q can occur at lower exposures. 
Sixteenth week to term of gestation Higher exposures can produce growth retardation and decreased 
brain size and intellect, although the effects are not as severe as 
occurs from similar exposures during mid-gestation. No documented 
risk for major anatomical malformations. Minimum lethal dose 
threshold for mental retardation (from animal studies) from 15 weeks 
to term > 1.5 Gy (150 rad) but decrease in I.Q. can occur at lower 
exposures 
*
Radiation exposure and risk at different gestational phases. There is no evidence that radiation exposure 
in the diagnostic ranges (<0. 10 Gy, <10 rad) is associated with measurably increased incidence of 
congenital malformation, stillbirth, miscarriage, growth retardation or mental retardation. 
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Table 3 Reproductive risks per million recognized pregnancies 
 
Reproductive Risks Frequency 
Immunologically & clinically diagnosed spontaneous abortions per million conceptions (< 20% 
has lethal malformations or chromosome abnormalities that cause abortion before the first month 
of gestation). 
350,000 
Clinically recognized spontaneous abortions per million clinically recognized pregnancies. 
Spontaneous abortion after the first missed menstrual period. 
150,000 
Genetic Diseases per million births 110,000 
 Multifactoral or polygenic genetic environmental interactions) 90,000 
 Dominantly inherited disease 10,000 
 Autosomal and sex-linked genetic disease 1,200 
 Cytogenetic (chromosomal abnormalities) 5,000 
 New mutations in the developing ova or sperm prior to conception 3,000 
Major malformations (genetic, unknown, environmental) 30,000 
Prematurity (Ireland 55,000; United States 124,000 69,000 
Fetal growth retardation 30,000 
Stillbirths (>20 wk.)      4,000-20,900 
Infertility 7% of couples 
Brent 1999 
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Table 4 
Risk of 10 rad (0.1 Gy) to Embryo* 
Risk Background Incidence Additional risk of 10 
rad (0.1 Gy) exposure 
Risk of very early pregnancy loss, 
before, the first missed period 
350,000/106  pregnancies 0 
Risk of spontaneous abortion  in a 
known pregnant women 
150,000/106  pregnancies 0 
Risk of major congenital 
malformations 
30,000/106 0 
Risk of severe mental retardation 5,000/106 0 
Risk of childhood leukemia/year  40/106 /year Very low increased 
risk, and possibly no 
measurably 
identifiable increased 
risk 
Risk of early- or late-onset genetic 
disease 
100,000/106 Very low risk is in 
next generation  
Prematurity 69,000/106 pregnancies 0 
Growth retardation 30,000/106 pregnancies 0 
Stillbirth 20-2000/106 pregnancies 0 
Infertility 7% of couples 0 
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Table 5 
Follow-up of adults with solid cancers in Hiroshima and Nagasaki who were in 
utero at the time of detonation of the A-bombs in 1945 
Results published in March 2008 (Preston et al 2008) 
Dose in Sv (rads) No. of patients No. of 
Cancers 
Person years % with solid 
Cancers 
<0.005  (<0.5) 1547 54 49,326 3.5 
0.005-<0.1  (0.5 to 10) 435 16 14,005 3.7 
0.1 to <0.2  (10 to <20) 168 6 5041 3.6 
0.2 to <0.5  (20 to <50) 172 8 5496 4.6 
0.5 to <1.0 (50 to <100) 92 7 2771 7.6 
>1.o 48 3 1404 6.2 
Total 2452 94 94 3.5 
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Table 6 
Follow-up of adults with solid cancers in Hiroshima and Nagasaki who were in children at the time of 
detonation of the A-bombs in 1945 
Results published in March 2008 (Preston et al 2008) 
Dose in Sv (rads) No. of patients No. of 
Cancers 
Person years % of  Cancers 
<0.005  (<0.5) 8549 318 247,744 3.7 
0.005-<0.1  (0.5 to 10) 4528 173 134,621 3.8 
0.1 to <0.2  (10 to <20) 853 38 25,802 4.4 
0.2 to <0.5  (20 to <50) 859 51 25,722 5.9 
0.5 to <1.0 (50 to <100) 325 21 9522 6.5 
>1.0 274 48 7620 17.5 
Total 15388 649 451,031 4.2 
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Table 7. Typical doses for selected medical procedures 
Type Description 
Embryo/Fetal 
Dose Range (mGy) 
Gonadal Dose 
(mGy) (Ovaries, 
Testes) 
x-ray Skull <0.01 <0.01, <0.01 
x-ray Chest <0.01 <0.01, <0.01 
x-ray Thoracic spine <0.01 <0.01, <0.01 
x-ray Mammography <0.01 <0.01, <0.01 
x-ray Barium meal 0.1-1.1  
x-ray Pelvis 0.1-1.1 1.2, 4.6 
x-ray Lumbar spine 1-2 4.3, 0.6 
x-ray Abdomen 1-3 2.2, 0.4 
x-ray Barium enema 7-8 16, 3.4 
CT Chest /CTPA 0.1-1  0.08, <0.01 
CT Abdomen 4-16 8.0, 0.7 
CT Pelvis 10-32  23, 1.7 
Chest fluoroscopy Chest <0.1 mGy/min  
IR fluoroscopy Abdominal fluoro 6 mGy/min  
Nuc Med Lung ventilation 0.1-0.3 0.13-0.5, 0.13-0.5 
Nuc Med Lung perfusion 0.1-0.4 0.06-0.27, 0.04-0.16  
Nuc Med White cell scan 0.7-1.4  
Nuc Med Renal scan 3-7 1.0-2.0, 0.7-1.4 
Nuc Med Bone scan 4.5-7 2.7-4.0, 1.8-2.7 
Nuc Med Cerebral blood flow 5-10 3.7-7.3, 1.3-2.7 
Nuc Med PET 8-16 5.6-11.1, 4.4-8.8 
Nuc Med Myocardial  
perfusion 
 
16.7-22.2 9.3-12.4, 2.7-3.6 
Nuc Med Therapy >50 31, 19 
 
